GoogleAnalysisGoogle DeepMind unveils AlphaGenome 2 predicting cell-state gene expression
What happened.Google DeepMind released AlphaGenome 2, an advanced genomic foundation model that predicts how single-letter DNA sequence variations alter cellular function across individual cell types and disease states.
Why it matters.Genetic variants manifest differently depending on specific cellular states and microenvironments. Resolving DNA impacts at single-cell resolution enables drug discovery teams to identify exact pathogenic mutations in diseased tissues without conducting multi-year wet-lab mutagenesis screens.
The technical specifications:
- Cellular resolution: Evaluates DNA sequences conditionally across individual cell types and activation states rather than relying on bulk tissue-level averages.
- Training foundation: Trained on more than 107 million single-cell profiles across 68 distinct biological tissues spanning human and mouse donors.
- Variant precision: Identified nearly double the causal regulatory variants that alter gene expression on immune benchmarks compared to previous biological architectures.
- Multimodal readouts: Maps gene expression, RNA splicing patterns, chromatin accessibility, histone marks, and DNA methylation from one-million-base sequence inputs.
- Dynamic generalization: Ingests user-supplied single-cell RNA sequencing data to evaluate novel disease trajectories without requiring model fine-tuning or retraining.
STORYLINE PROGRESSION & CONTEXT
This report represents a verified evolution of prior newsroom intelligence: